临床药师参与病毒性肝炎肝硬化伴腹水患者治疗的药学监护

Pharmaceutical Care for One Patient with Viral Hepatitis Cirrhosis Complicated with Ascites by Clinical Pharmacists

目的:探讨肝硬化腹水患者临床治疗的药学监护措施,为优化临床药物治疗提供参考。方法:对1例病毒性肝炎肝硬化伴腹水患者治疗过程所用药物进行分析,根据其疾病特点、病情变化等协助医师制订有效的治疗方案,并对患者开展用药教育。结果:在临床药师参与下,通过对利尿、保肝治疗的药学监护,患者得到了较好的个体化治疗,肝硬化腹水明显减少。结论:临床药师可利用自身所掌握的药学知识,从药物选择、对患者的用药教育、药品不良反应等方面寻找切入点,提高患者用药的安全性、合理性。

OBJECTIVE： To investigate the pharmaceutical care for one patient with viral hepatitis cirrhosis complicated with ascites,so as to provide reference for the optimization of clinical drug treatment. METHODS：Statistical analysis was conducted on the treatment drug of one patient with viral hepatitis cirrhosis complicated with ascites,the clinical pharmacists assisted the clinicians to formulate the effective treatment regimen according to the characteristics and changes of diseases. And medication education was conducted on the patient. RESULTS： With the participation of clinical pharmacists,through the pharmaceutical care of diuresis and liver treatment,the patient received better individualized treatment,and ascites of cirrhosis reduced significantly. CONCLUSIONS： The clinical pharmacists can take full advantage of the pharmaceutical knowledge to improve the medication safety and rationality in patients according to the entry points as selection of drugs,medication education and adverse drug reactions,etc..